Newsroom

HOUSTON--(BUSINESS WIRE)--Fraud lawsuit brought against Beaumont businessman Muhammad Tahir Javed....

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Inc. (“Encoded”), a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced the appointment of Dr. Joseph Sullivan M.D., as Vice President of Clinical Development. In this role, Dr. Sullivan will be responsible for leading all clinical development activities at Encoded and will report directly to the Company’s Chief Medical Officer, Sal Rico, M.D., Ph.D. “Joe’s unparal...

MEDELLÍN, Colombia--(BUSINESS WIRE)--Mineros S.A. (TSX: MSA; OTCQX: MNSAF; BVC: MINEROS) (“Mineros” or the “Company”) today announced the formal launch of its work program to advance the La Pepa Project in Chile, together with the appointment of Mr. Rafael Casas Plata as Project Manager. The Company has also voluntarily filed a National Instrument 43-101 (“NI 43-101”) compliant technical report for the La Pepa Project on SEDAR+. “Rafael’s appointment and the mobilization of exploration and deve...

AMSTERDAM--(BUSINESS WIRE)--PPG (NYSE: PPG) today announced that its Architectural Coatings manufacturing sites in Amsterdam, the Netherlands and Søborg, Denmark have received REDCert² certification, which verifies the use of sustainable raw materials through a certified chain of custody. REDCert² uses the mass balance approach, a recognized method for attributing the sustainability value of certified inputs. This ensures that PPG’s products reflect responsible sourcing throughout the manufactu...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 15.12.2025 FVD. IE00BKVKW020 250,002.00 USD 7,055,932.98 28.224  ...

ATLANTA--(BUSINESS WIRE)--Vestis Corporation (NYSE: VSTS), a leading provider of uniforms and workplace supplies, today announced that Kelly Janzen, Executive Vice President and Chief Financial Officer, will depart the company to pursue other opportunities. Ms. Janzen will remain with Vestis through the end of calendar year 2025 to facilitate a smooth transition. Vestis has engaged a leading executive search firm to conduct a comprehensive internal and external search for a permanent Chief Fina...

NEWTON, Mass.--(BUSINESS WIRE)--TechTarget, Inc. (Nasdaq: TTGT), (“Informa TechTarget”), a leading growth accelerator for the B2B Technology sector, today announced that Gary Nugent, Chief Executive Officer, and Dan Noreck, Chief Financial Officer, will participate in a fireside chat at the Needham Growth Conference on Tuesday, January 13, 2026, at the Lotte NY Palace Hotel in New York, NY. The presentation is scheduled to begin at 8:00 a.m. ET with a live webcast and a replay accessible from t...

DAVENPORT, Iowa--(BUSINESS WIRE)--Von Maur Department Stores announced today plans to open a new anchor store at Macerich’s Freehold Raceway Mall in Freehold, New Jersey, with an anticipated opening in Fall 2027. The new location will mark the company’s first store in New Jersey, expanding its presence in the Northeast and introducing its signature customer service and upscale shopping experience to Central New Jersey. Von Maur, recognized as America’s Best Department Store by Newsweek for four...

SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and developer of the Revi® System for urgency urinary incontinence (UUI), today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its enhanced Revi wearable designed to deliver therapy more effectively and seamlessly support long-term symptom relief for patients. Since 2010, BlueWind has pioneered and advanced iTNM for UUI, evolving it from an...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Cosette’s Abbreviated New Drug Application (ANDA) for the first generic version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days of Competitive Generic Therapy (CGT) exclusivity. Cosette has commenced commercial shipments, triggering the 180 days of market...